THE THERAPEUTIC
OBJECTIVES IN THE USE OF ANTIANGINAL DRUGS
The major therapeutic objectives in the treatment of angina are aimed at terminating or preventing an acute attack and increasing the patient’s exercise capacity. These objectives can be achieved by reducing overall myocardial oxygen demand or by increasing oxygen sup-ply to ischemic areas. A decrease in myocardial oxygen demand can be attained through use of the organic ni-trates, calcium entry blockers, and β-adrenoceptor block-ing agents. Increases in myocardial oxygen supply are more difficult to achieve, especially when coronary blood vessels are partially or totally obstructed.
However, re-distribution of blood flow to the subendocardium of ischemic areas has been
documented in experimental an-imals following nifedipine (Adalat, Procardia), diltiazem (Cardizem),verapamil
(Calan), amlodipine (Norvasc), ni-troglycerin (Nitrostat, Tridil, Nitro-Dur), or
propranolol (Inderal) administration.
Increases in collateral flow to ischemic areas also have been observed in
experimental animals and humans after treatment with certain calcium entry
blockers and organic nitrates.
When coronary vasospasm
occurs, the balance be-tween oxygen supply and demand can be restored by
re-lieving the spasm, thereby restoring normal coronary blood flow. Acute vasospasm
has been successfully aborted through the use of nitroglycerin. In contrast,
cal-cium entry blockers and long-acting nitrates have proved effective in the
chronic therapy of coronary vasospasm.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.